Medicines

  1. Libtayo (cemiplimab-rwlc)
    Libtayo (cemiplimab-rwlc)
    by Sanofi
    for Skin Cancer
    €17,380.00
  2. Eril (fasudil hydrochloride)
    Eril (fasudil hydrochloride)
    by Various
    for Cerebrovascular Disorder
    €478.00
  3. Nuedexta (dextromethorphan HBr and quinidine sulfate)
    Nuedexta (dextromethorphan HBr and quinidine sulfate)
    by Avanir Pharmaceuticals
    for Pseudobulbar Affect (PBA)
    €1,536.00
  4. Relumina (relugolix)
    Relumina (relugolix)
    by Takeda Pharma A/S
    for
    €1,256.40
  5. Orilissa (elagolix)
    Orilissa (elagolix)
    by AbbVie Ltd
    for
    €1,050.06
  6. Takhzyro (lanadelumab)
    Takhzyro (lanadelumab)
    by Shire Pharmaceuticals
    for Hereditary angioedema (HAE)
    €17,768.40
  7. Cablivi (caplacizumab)
    Cablivi (caplacizumab)
    by Ablynx NV
    for
    €6,792.00
  8. Lorbrena/Lorviqua (lorlatinib)
    Lorbrena/Lorviqua (lorlatinib)
    by Pfizer Limited
    for Lung Cancer
    €8,382.72
  9. Kalydeco (ivacaftor)
    Kalydeco (ivacaftor)
    by Vertex Pharmaceuticals (Europe) Ltd
    for Cystic Fibrosis
    €11,800.00
View as Grid List

Items 1-9 of 72

Page
per page
Set Descending Direction